Mitracept Overview
- Year Founded
-
2023
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Mitracept General Information
Description
Developer of a medical alternative technology designed to address the issue of mitral valve regurgitation. The company's technology reduces the risk of left ventricular outflow tract obstruction during transcatheter mitral valve replacement, enabling healthcare providers to improve patients' condition with a less invasive treatment option.
Contact Information
Website
www.mitracept.comCorporate Office
- Paasheuvelweg 25-D5
- 1105 BP Amsterdam
- Netherlands
Corporate Office
- Paasheuvelweg 25-D5
- 1105 BP Amsterdam
- Netherlands
Mitracept Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 23-Sep-2025 | Completed | Out of Business | |||
| 2. Seed Round | 20-Feb-2024 | Completed | Startup | |||
| 1. Accelerator/Incubator | Completed | Startup |
Mitracept FAQs
-
When was Mitracept founded?
Mitracept was founded in 2023.
-
Where is Mitracept headquartered?
Mitracept is headquartered in Amsterdam, Netherlands.
-
What industry is Mitracept in?
Mitracept’s primary industry is Decision/Risk Analysis.
-
Is Mitracept a private or public company?
Mitracept is a Private company.
-
What is Mitracept’s current revenue?
The current revenue for Mitracept is .
-
How much funding has Mitracept raised over time?
Mitracept has raised $162K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process